Supply Agreements in the Biotechnology Industry

393 Contracts & Agreements

Browse by Company

89bio, Inc. (1 contract)
ACADIA PHARMACEUTICALS INC (4)
ACHIEVE LIFE SCIENCES, INC. (2)
Acorda Therapeutics (5)
Adamas Pharmaceuticals Inc (3)
Adhera Therapeutics, Inc. (2)
ADMA BIOLOGICS, INC. (2)
Advaxis, Inc. (1)
AGENUS INC (2)
Aimmune Therapeutics, Inc. (2)
Akebia Therapeutics, Inc. (11)
ALBIREO PHARMA, INC. (4)
Alexion Pharmaceuticals (1)
Alkermes plc. (6)
Alliqua BioMedical, Inc. (2)
Alpha Healthcare Acquisition Corp. (3)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (9)
Amgen Inc. (4)
AMICUS THERAPEUTICS, INC. (1)
Anika Therapeutics (1)
Apellis Pharmaceuticals, Inc. (1)
Aprea Therapeutics, Inc. (1)
Aptevo Therapeutics Inc. (1)
Aravive, Inc. (5)
Arcturus Therapeutics Holdings Inc. (1)
Arcutis Biotherapeutics, Inc. (2)
ARENA PHARMACEUTICALS INC (2)
Athenex, Inc. (2)
ATOSSA GENETICS INC (1)
Aurinia Pharmaceuticals Inc. (2)
BELLICUM PHARMACEUTICALS, INC (1)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BIOTIME INC (2)
bluebird bio, Inc. (5)
Bolt Biotherapeutics, Inc. (2)
Bone Biologics Corp (1)
Cabaletta Bio, Inc. (1)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
CATALYST BIOSCIENCES, INC. (2)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Century Therapeutics, Inc. (1)
ChemoCentryx, Inc. (1)
CHIMERIX INC (2)
Conatus Pharmaceuticals Inc. (1)
CTI BIOPHARMA CORP (1)
Cyclacel Pharmaceuticals, Inc. (1)
CytoDyn Inc. (11)
CYTRX CORP (1)
Deciphera Pharmaceuticals, Inc. (2)
Dermavant Sciences Ltd (2)
DiaMedica Therapeutics Inc. (1)
DYNAVAX TECHNOLOGIES CORP (12)
Eagle Pharmaceuticals, Inc. (3)
Edge Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (1)
Emergent BioSolutions Inc. (1)
Equillium, Inc. (2)
Evelo Biosciences, Inc. (1)
Exelixis (6)
FIBROGEN INC (5)
Flex Pharma, Inc. (1)
Flexion Therapeutics Inc (8)
FS Development Corp. (2)
GALECTIN THERAPEUTICS INC (1)
Gemphire Therapeutics Inc. (2)
GENEREX BIOTECHNOLOGY CORP (1)
Gilead Sciences (8)
Grail, Inc. (1)
HEMISPHERX BIOPHARMA INC (3)
HISTOGENICS CORP (3)
Homology Medicines, Inc. (1)
HUMANIGEN, INC (1)
IMMUCELL CORP (1)
IMMUNOGEN INC (1)
INSMED Inc (2)
Inspyr Therapeutics, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (4)
IRONWOOD PHARMACEUTICALS INC (3)
Isoray, Inc. (9)
Kadmon Holdings, Inc. (2)
Kindred Biosciences, Inc. (3)
Kiniksa Pharmaceuticals, Ltd. (1)
LEXICON PHARMACEUTICALS, INC. (2)
Ligand Pharmaceuticals Incorporated (11)
MACROGENICS INC (2)
MANNKIND CORP (13)
Marker Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (1)
MEI Pharma, Inc. (1)
Minerva Neurosciences, Inc. (1)
Myovant Sciences Ltd. (5)
NantKwest, Inc. (1)
Natera, Inc. (7)
NAVIDEA BIOPHARMACEUTICALS, INC. (1)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
Neurotrope, Inc. (1)
NOVAVAX INC (5)
OncBioMune Pharmaceuticals, Inc (1)
ONCOSEC MEDICAL Inc (1)
OPGEN INC (1)
Ophthotech Corp. (1)
PALATIN TECHNOLOGIES INC (3)
PDL BIOPHARMA, INC. (2)
PhaseBio Pharmaceuticals Inc (1)
PORTOLA PHARMACEUTICALS INC (2)
Progenics Pharmaceuticals, Inc. (1)
PROGENITY, INC. (2)
Protalix BioTherapeutics, Inc. (2)
PUMA BIOTECHNOLOGY, INC. (1)
Radius Health, Inc. (6)
Regeneron Pharmaceuticals (7)
RenovoRx, Inc. (1)
Retrophin, Inc. (3)
RIGEL PHARMACEUTICALS INC (1)
RITTER PHARMACEUTICALS INC (2)
Sage Therapeutics, Inc. (3)
Sana Biotechnology, Inc. (2)
Sarepta Therapeutics, Inc. (1)
Savara Inc (4)
SEATTLE GENETICS INC (14)
Seres Therapeutics, Inc. (2)
SOLIGENIX, INC. (1)
SOPHIRIS BIO INC. (1)
Spectrum Pharmaceuticals, Inc. (9)
SPHERIX INC (1)
SYNLOGIC, INC. (1)
T2 Biosystems, Inc. (6)
TENAX THERAPEUTICS, INC. (1)
Translate Bio, Inc. (1)
TREVENA INC (1)
Twist Bioscience Corp (2)
U.S. Stem Cell, Inc. (2)
Ultragenyx Pharmaceutical Inc. (4)
United Therapeutics Corp (3)
UroGen Pharma Ltd. (3)
Vaxart, Inc. (1)
Vaxcyte, Inc. (2)
VBI Vaccines Inc (1)
Vericel Corp (4)
VICAL INC (5)
Viela Bio, Inc. (2)
VITRO DIAGNOSTICS INC (2)
WINDTREE THERAPEUTICS INC (2)
Xencor Inc (2)

Recent Contracts

Master Services Agreement for Product Supply between Marker Therapeutics, Inc. and Cell Ready LLC dated February 22, 2024 (Marker Therapeutics, Inc., Filed With SEC on March 26, 2024)
Amendment 2 to Manufacturing & Supply Agreement, dated as of December 28, 2023 by and between UroGen Pharma Ltd. and Cenexi-Laboratoires Thissen s.a (UroGen Pharma Ltd., Filed With SEC on March 14, 2024)
Amendment No. 2 to the Manufacture and Supply Agreement, dated December 13, 2023 entered into by and between Savara ApS GEMABIOTECH SAU (Savara Inc, Filed With SEC on March 7, 2024)
Supply Agreement, dated September 15, 2015, by and between Registrant and GenIbet BioPharmaceuticals, SA, as amended (Seres Therapeutics, Inc., Filed With SEC on March 5, 2024)
Eighth Amendment to Supply Agreement, dated December 31, 2023, by and between the Registrant and Illumina, Inc (Natera, Inc., Filed With SEC on February 29, 2024)
Commercial Supply Agreement, dated March 1, 2023, by and between the Registrant and CoreRx Inc., as amended by Amendment No. 1, dated August 1, 2023 (ACADIA PHARMACEUTICALS INC, Filed With SEC on February 28, 2024)
Commercial Supply Agreement, dated December 15, 2021, by and between the Registrant and F.I.S. Fabbrica Italiana Sintetici S.p.A (ACADIA PHARMACEUTICALS INC, Filed With SEC on February 28, 2024)
Master Commercial Supply Agreement, dated November 16, 2022, by and between the Registrant and Corden Pharma Bergamo S.p.A (ACADIA PHARMACEUTICALS INC, Filed With SEC on February 28, 2024)
Commercial Manufacturing and Supply Agreement by and between the Registrant and Lonza Ltd., dated October 13, 2023 (Vaxcyte, Inc., Filed With SEC on February 27, 2024)
Commercial Supply Agreement, dated June 19, 2023, between Ultragenyx Pharmaceutical Inc. and IOI Oleo GmbH (Ultragenyx Pharmaceutical Inc., Filed With SEC on February 21, 2024)
Supply Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 29, 2024)
Supply Agreement, dated July 5, 2023, by and between VBI Vaccines Inc. and Brii Biosciences (VBI Vaccines Inc, Filed With SEC on November 14, 2023)
Supply Agreement, effective as of September 7, 2023, by and between Company and Nitto Denko Avecia Inc (DYNAVAX TECHNOLOGIES CORP, Filed With SEC on November 2, 2023)
Supply Agreement, dated September 26, 2003, by and between Acorda Therapeutics, Inc. and Elan Corporation, plc (Alkermes plc., Filed With SEC on October 25, 2023)
Manufacturing and Supply Agreement - Amendment No. 2, dated May 19, 2023, by and between the Registrant and Isotopia Molecular Imaging Ltd (UroGen Pharma Ltd., Filed With SEC on August 10, 2023)
Clinical Supply Agreement, dated May 22, 2017, by and between Registrant and Biocon SA (which was subsequently assigned to Biocon Limited effective March 2018) (Equillium, Inc., Filed With SEC on August 9, 2023)
Supply and Manufacturing Services Agreement, dated as of March 31, 2023, by and among the Company, WuXi Biologics (Hong Kong) Limited, WuXi Biologics Ireland Limited and WuXi... (AMICUS THERAPEUTICS, INC., Filed With SEC on August 8, 2023)
Amendment No. 3 to Supply Agreement, by and between the Registrant and CyDex Pharmaceuticals, Inc., dated September 25, 2015 (Sage Therapeutics, Inc., Filed With SEC on August 7, 2023)
Supply Agreement by and between the Registrant and CyDex Pharmaceuticals, Inc., dated December 13, 2012, as amended August 21, 2013 and April 30, 2014 (Sage Therapeutics, Inc., Filed With SEC on August 7, 2023)
Amendment No. 3 to Supply Agreement, dated effective as of April 26, 2023, by and between Company and Biological E. Limited (DYNAVAX TECHNOLOGIES CORP, Filed With SEC on August 3, 2023)
Amendment to the Agreement for the Supply of Manufactured Products, dated May 15, 2023, between Intercept Pharma Europe Ltd. and Amdipharm Ltd (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on May 18, 2023)
Commercial Manufacturing and Supply Agreement, dated March 14, 2023, between the Registrant and Agilent Technologies, Inc (Ophthotech Corp., Filed With SEC on May 10, 2023)
Second Amendment to Supply Agreement, dated as of January 1, 2022, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Spectrum Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
First Amendment to Supply Agreement, dated as of December 6, 2019, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Spectrum Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
Supply Agreement, dated as of February 28, 2018, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Spectrum Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
Fourth Amendment to Commercial Supply Agreement, dated December 22, 2022, by and between MannKind Corporation and United Therapeutics Corporation (MANNKIND CORP, Filed With SEC on February 23, 2023)
Third Amendment to Commercial Supply Agreement, dated August 31, 2022, by and between MannKind Corporation and United Therapeutics Corporation (MANNKIND CORP, Filed With SEC on February 23, 2023)
Second Amendment to Commercial Supply Agreement, dated June 15, 2022, by and between MannKind Corporation and United Therapeutics Corporation (MANNKIND CORP, Filed With SEC on February 23, 2023)
First Amendment to Master Manufacturing Supply Agreement, effective as of November 14, 2022, between the Company and STA Pharmaceutical Hong Kong Limited, a subsidiary of WuXi... (Retrophin, Inc., Filed With SEC on February 23, 2023)
Supply Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 30, 2023)
Form of Supply Agreement between Eisai and the Company (certain identified information has been excluded from the exhibit because it both (i) is not material and (ii) would be... (CATALYST PHARMACEUTICALS, INC., Filed With SEC on December 22, 2022)
Manufacturing and Supply Agreement, dated May 30, 2020, by and between the Registrant and Isotopia Molecular Imaging Ltd. (the Isotopia Agreement) and the extension to the... (UroGen Pharma Ltd., Filed With SEC on November 10, 2022)
Letter of Amendment to the Amended and Restated SARS-CoV-2 Vaccine Supply Agreement, dated as of September 26, 2022, between the Company and The Secretary of State for Business,... (NOVAVAX INC, Filed With SEC on November 9, 2022)
Amended and Restated SARS-CoV-2 Vaccine Supply Agreement, dated as of July 1, 2022, between the Company and The Secretary of State for Business, Energy, and Industrial Strategy,... (NOVAVAX INC, Filed With SEC on November 9, 2022)
Amendment No. 1 to Sourcing and Supply Agreement, dated July 14, 2022, by and between Amgen USA Inc., a wholly owned subsidiary of Amgen Inc., and DaVita Inc (Amgen Inc., Filed With SEC on November 4, 2022)
Modification P00007 to Supply Agreement, dated as of July 29, 2022, by and between the Registrant and the U.S. Army Contracting Command, New Jersey (Regeneron Pharmaceuticals, Filed With SEC on November 3, 2022)
Modification P00003 to Supply Agreement, dated as of July 8, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey (Regeneron Pharmaceuticals, Filed With SEC on November 3, 2022)
Modification P00002 to Supply Agreement, dated as of June 17, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey (Regeneron Pharmaceuticals, Filed With SEC on November 3, 2022)
Modification P00001 to Supply Agreement, dated as of March 9, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey (Regeneron Pharmaceuticals, Filed With SEC on November 3, 2022)
Amendment No. 2 to Supply Agreement, dated effective as of September 30, 2022, by and between the Company and Biological E. Limited (DYNAVAX TECHNOLOGIES CORP, Filed With SEC on November 3, 2022)